Evidence for human placental kappa opiate receptor down regulation due to methadone use during pregnancy

M. S. Ahmed, T. D. Schoof, D. Zhou, K. Sagduyu, D. Maulik

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Scopus citations

Abstract

Placentas obtained from patients with documented chronic opiate use during pregnancy, methadone maintenance program, exhibit opiate receptor down regulation. Evidence of this phenomenon is provided by the absence of the receptor binding sites and its functions.

Original languageEnglish (US)
Title of host publicationNew leads in opioid research
Subtitle of host publicationproceedings of the International Narcotics Research Conference. ICS914
EditorsJ.M. Van Ree, A.H. Mulder, V.M. Wiegant, T.B. Van Wimersma Greidanus, J.M. Van Ree, A.H. Mulder, V.M. Wiegant, T.B. Van Wimersma Greidanus
PublisherElsevier Science Publishers B.V.
Pages135-136
Number of pages2
ISBN (Print)044481213X
StatePublished - Jan 1 1990
Externally publishedYes
EventThe International Narcotics Research Conference -
Duration: Jul 8 1989Jul 13 1989

Publication series

NameNew leads in opioid research: proceedings of the International Narcotics Research Conference. ICS914

Other

OtherThe International Narcotics Research Conference
Period7/8/897/13/89

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ahmed, M. S., Schoof, T. D., Zhou, D., Sagduyu, K., & Maulik, D. (1990). Evidence for human placental kappa opiate receptor down regulation due to methadone use during pregnancy. In J. M. Van Ree, A. H. Mulder, V. M. Wiegant, T. B. Van Wimersma Greidanus, J. M. Van Ree, A. H. Mulder, V. M. Wiegant, & T. B. Van Wimersma Greidanus (Eds.), New leads in opioid research: proceedings of the International Narcotics Research Conference. ICS914 (pp. 135-136). (New leads in opioid research: proceedings of the International Narcotics Research Conference. ICS914). Elsevier Science Publishers B.V..